DVL1

DVL1 is a cytoplasmic scaffolding protein that transduces Wnt signals downstream of Frizzled receptors through both canonical (β-catenin-dependent) and non-canonical/planar cell polarity (PCP) pathways, and additionally functions as a nuclear transcriptional regulator. In canonical Wnt signaling, CKIε phosphorylates DVL1 to promote its interaction with Frat-1 and cooperative activation of β-catenin/TCF transcription (PMID:12556519); DVL1 also engages Axin1 through DIX–DIX domain interactions to modulate the β-catenin destruction complex (PMID:20846493), and its phase separation into biomolecular condensates can drive ligand-independent Wnt activation by promoting Tankyrase-mediated Axin1 degradation (PMID:41929184). In the nucleus, DVL1 accumulates at rDNA loci in response to Wnt5a to repress RNA Pol I transcription (PMID:27500936), co-localizes with H3K27me3/EZH2-marked chromatin (PMID:34659647), and regulates myoblast proliferation through a β-catenin-independent mechanism (PMID:35589804). Heterozygous frameshift mutations in exon 14 of DVL1 that generate a novel basic C-terminal tail cause autosomal-dominant Robinow syndrome by impairing CKIε-dependent phosphorylation and shifting signaling from canonical toward non-canonical Wnt/JNK output (PMID:25817016, PMID:36916233).

1. 1997 High

   Establishing that Dvl1 has a non-redundant in vivo role in complex behavior, Dvl1-knockout mice revealed deficits in social interaction and sensorimotor gating (prepulse inhibition) despite normal viability and fertility.

   Evidence Gene-targeted knockout mice with behavioral phenotyping

   PMID:14960015 PMID:9298901

   Open questions at the time

   • Neuroanatomical and circuit-level mechanisms underlying the behavioral phenotype were undefined
   • Redundancy with Dvl2/Dvl3 in the CNS was not dissected
2. 1999 Medium

   A yeast two-hybrid screen identified EPS8 as a PDZ-domain interactor of DVL1, suggesting DVL1 interfaces with receptor tyrosine kinase signaling beyond Wnt pathways.

   Evidence Yeast two-hybrid, in vitro binding, co-transfection phosphorylation assays

   PMID:10581192

   Open questions at the time

   • No in vivo validation of DVL1–EPS8 interaction
   • Functional consequence for EGFR signaling in physiological contexts not tested
3. 2003 High

   The mechanism by which DVL1 activates canonical Wnt signaling was resolved: CKIε phosphorylates DVL1 to enhance its binding to Frat-1 (via residues 228–250), and this complex cooperatively stabilizes β-catenin and activates TCF-4 transcription.

   Evidence Co-IP, deletion mutant mapping, TOPFlash reporter, RNAi knockdown of CKIε

   PMID:12556519

   Open questions at the time

   • Structural basis of the CKIε–DVL1–Frat-1 ternary complex was not determined
   • Specific CKIε phosphorylation sites on DVL1 were not mapped
4. 2010 Medium

   Biochemical reconstitution demonstrated that DVL1 and Axin1 interact directly through their DIX domains, providing a molecular basis for DVL1's recruitment to the β-catenin destruction complex.

   Evidence Co-expression of DIX domains, affinity chromatography, size-exclusion chromatography, crystallization

   PMID:20846493

   Open questions at the time

   • High-resolution structure of the DVL1–Axin1 DIX complex was not solved
   • Stoichiometry and polymerization state in cells were not determined
5. 2011 High

   DVL1's role in non-canonical PCP signaling was defined: DVL1 hyperphosphorylates Frizzled3 to prevent its internalization, thereby inhibiting PCP signal propagation, while Vangl2 antagonizes this effect to sharpen gradient sensing in commissural axon growth cones.

   Evidence In vivo axon guidance assays, overexpression/knockdown, Frizzled3 phosphorylation and internalization measurements

   PMID:21316586

   Open questions at the time

   • Kinase responsible for DVL1-induced Frizzled3 phosphorylation was not identified
   • Whether this mechanism generalizes beyond commissural axons was not tested
6. 2015 High

   The genetic basis of DVL1-associated Robinow syndrome was established: heterozygous frameshift mutations in exon 14 escape NMD and produce C-terminally altered proteins that cause autosomal-dominant osteosclerotic Robinow syndrome, with co-expression of mutant and wild-type alleles paradoxically enhancing canonical Wnt reporter activity.

   Evidence Whole-exome sequencing of multiple families, transcript validation in patient leukocytes, TOPFlash reporter assays with mutant constructs

   PMID:25817014 PMID:25817016

   Open questions at the time

   • Precise molecular mechanism of the dominant interaction between mutant and wild-type DVL1 was not resolved
   • Tissue-specific consequences of the mutant allele were not tested in vivo
7. 2016 High

   DVL1 was revealed to have a paralog-specific nuclear function: Wnt5a drives DVL1 accumulation at nucleolar organizer regions where it displaces SIRT7 from rDNA and disassembles the RNA Pol I transcription machinery, repressing ribosomal RNA transcription.

   Evidence Paralog-specific siRNA, ChIP at rDNA loci, immunofluorescence co-localization, Pol I transcription assay

   PMID:27500936

   Open questions at the time

   • How Wnt5a signaling specifically directs DVL1 (not DVL2/3) to the nucleolus was unknown
   • Downstream physiological impact of rRNA repression was not addressed
8. 2016 High

   Dvl1 loss-of-function in the gut was shown to disrupt both epithelial (Paneth cell) and immune (CD8+ T cell) homeostasis, with bone marrow chimera experiments demonstrating that both compartments contribute to gastrointestinal dysfunction.

   Evidence Dvl1−/− knockout mice, bone marrow chimera, histology, gut transit measurements

   PMID:27525310

   Open questions at the time

   • Wnt pathway branch (canonical vs. non-canonical) mediating epithelial versus immune phenotypes was not resolved
   • Microbiota-dependent versus -independent contributions were incompletely dissected
9. 2018 Medium

   Post-translational control of DVL1 stability was identified: Neuroglobin directly binds DVL1 and promotes its proteasomal degradation, thereby inhibiting both DVL1-mediated canonical Wnt and NF-κB signaling.

   Evidence Co-immunoprecipitation, co-localization, TOPFlash reporter, proteasome inhibitor rescue

   PMID:30041403

   Open questions at the time

   • Whether Neuroglobin recruits a specific E3 ligase to DVL1 was not determined
   • Physiological context (cell type, stimulus) for Neuroglobin–DVL1 regulation was not established
10. 2019 Medium

    Acetylation was identified as a key post-translational modification regulating DVL1 nuclear–cytoplasmic partitioning: mass spectrometry mapped 12 acetylated lysines, and site-directed mutagenesis showed that K69 (DIX) and K285 (PDZ) acetylation promotes nuclear accumulation and chromatin binding.

    Evidence LC-MS/MS, site-directed mutagenesis, subcellular fractionation, ChIP in triple-negative breast cancer cells

    PMID:31700102

    Open questions at the time

    • Acetyltransferase(s) and deacetylase(s) responsible were not identified
    • Functional consequence for specific target gene expression was not determined
11. 2021 Medium

    ChIP-Seq demonstrated that nuclear DVL1 occupies genomic regions co-marked with H3K27me3 and EZH2, linking DVL1 to Polycomb-mediated transcriptional repression.

    Evidence ChIP-Seq with bioinformatic co-localization analysis of DVL1, H3K27me3, and EZH2 peaks

    PMID:34659647

    Open questions at the time

    • Direct physical interaction between DVL1 and PRC2 components was not shown
    • Causal role of DVL1 in establishing or maintaining H3K27me3 marks was not tested
12. 2022 Medium

    Nuclear DVL1 was shown to regulate myoblast proliferation independently of β-catenin nuclear translocation and without requiring its DIX or PDZ domains, establishing a domain-distinct nuclear mechanism separable from canonical Wnt scaffolding.

    Evidence siRNA knockdown, nuclear localization mutants, BrdU proliferation assay in human myoblasts

    PMID:35589804

    Open questions at the time

    • Nuclear binding partners mediating DVL1's proliferative effect were not identified
    • Whether this mechanism operates in vivo during myogenesis was untested
13. 2023 High

    DVL1 was found to regulate a non-Wnt GPCR: it interacts with somatostatin receptor 2 (SSTR2) in a ligand-independent manner and targets it for lysosomal degradation, suppressing agonist-stimulated ERK1/2 activation.

    Evidence Co-IP, receptor internalization/recycling assays, lysosomal inhibitor rescue, ERK1/2 phosphorylation assay

    PMID:36965619

    Open questions at the time

    • Domain of DVL1 responsible for SSTR2 interaction was not mapped
    • Whether other GPCRs are similarly regulated by DVL1 was not explored
14. 2023 High

    In vivo functional studies of Robinow frameshift variants in Drosophila and chicken resolved the signaling shift: mutant DVL1 loses canonical Wnt output while gaining non-canonical Wnt/JNK signaling, leading to ectopic MMP1, apoptosis, and aberrant collagen IV deposition.

    Evidence Transgenic Drosophila and chicken embryo expression of human DVL1 variants, TOPFlash/PCP reporters, MMP1/collagen IV immunostaining, caspase inhibitor rescue

    PMID:36916233

    Open questions at the time

    • Whether JNK hyperactivation is the primary driver of skeletal phenotypes in Robinow patients was not determined
    • Tissue-specific signaling balance in mammalian models was not assessed
15. 2024 Medium

    The E3 ubiquitin ligase HECW1 was identified as a direct regulator of DVL1 turnover: HECW1 ubiquitinates DVL1 for degradation, and loss of HECW1 stabilizes DVL1, hyperactivating Wnt/β-catenin signaling and promoting cervical cancer cell proliferation.

    Evidence Ubiquitination assay, Co-IP, TOPFlash reporter, xenograft tumor model

    PMID:38266865

    Open questions at the time

    • Specific ubiquitination sites on DVL1 targeted by HECW1 were not mapped
    • Relationship between HECW1 and Neuroglobin-mediated DVL1 degradation was not addressed

• Key unresolved questions include: the structural basis for how the Robinow frameshift C-terminal tail blocks CKIε phosphorylation and locks DVL1 in puncta; the identity of nuclear interaction partners that mediate DVL1's β-catenin-independent proliferative and Polycomb-associated functions; and whether DVL1 phase separation is regulated physiologically to tune Wnt signaling in specific tissues.
• No high-resolution structure of full-length DVL1 or the Robinow mutant C-terminal tail
• Nuclear DVL1 interactome is incomplete
• In vivo significance of DVL1 condensate regulation (e.g., by Nup358) awaits peer-reviewed confirmation